Literature DB >> 29875029

Effect of Daytime Blue-enriched LED Light on the Nighttime Circadian Melatonin Inhibition of Hepatoma 7288CTC Warburg Effect and Progression.

Robert T Dauchy1, Melissa A Wren-Dail2, Lynell M Dupepe3, Steven M Hill2, Shulin Xiang2, Muralidharan Anbalagan2, Victoria P Belancio2, Erin M Dauchy2, David E Blask2.   

Abstract

Liver cancer is the second leading cause of cancer death worldwide. Metabolic pathways within the liver and liver cancers are highly regulated by the central circadian clock in the suprachiasmatic nuclei (SCN). Daily light and dark cycles regulate the SCN-driven pineal production of the circadian anticancer hormone melatonin and temporally coordinate circadian rhythms of metabolism and physiology in mammals. In previous studies, we demonstrated that melatonin suppresses linoleic acid metabolism and the Warburg effect (aerobic glycolysis)in human breast cancer xenografts and that blue-enriched light (465-485 nm) from light-emitting diode lighting at daytime (bLAD) amplifies nighttime circadian melatonin levels in rats by 7-fold over cool white fluorescent (CWF) lighting. Here we tested the hypothesis that daytime exposure of tissue-isolated Morris hepatoma 7288CTC-bearing male rats to bLAD amplifies the nighttime melatonin signal to enhance the inhibition of tumor growth. Compared with rats housed under a 12:12-h light:dark cycle in CWF light, rats in bLAD light evinced a 7-fold higher peak plasma melatonin level at the mid-dark phase; in addition, high melatonin levels were prolonged until 4 h into the light phase. After implantation of tissue-isolated hepatoma 7288CTC xenografts, tumor growth rates were markedly delayed, and tumor cAMP levels, LA metabolism, the Warburg effect, and growth signaling activities were decreased in rats in bLAD compared with CWF daytime lighting. These data show that the increased nighttime circadian melatonin levels due to bLAD exposure decreases hepatoma metabolic, signaling, and proliferative activities beyond what occurs after normal melatonin signaling under CWF light.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29875029      PMCID: PMC6103418          DOI: 10.30802/AALAS-CM-17-000107

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  57 in total

1.  JTK_CYCLE: an efficient nonparametric algorithm for detecting rhythmic components in genome-scale data sets.

Authors:  Michael E Hughes; John B Hogenesch; Karl Kornacker
Journal:  J Biol Rhythms       Date:  2010-10       Impact factor: 3.182

2.  Melanopsin-expressing ganglion cells in primate retina signal colour and irradiance and project to the LGN.

Authors:  Dennis M Dacey; Hsi-Wen Liao; Beth B Peterson; Farrel R Robinson; Vivianne C Smith; Joel Pokorny; King-Wai Yau; Paul D Gamlin
Journal:  Nature       Date:  2005-02-17       Impact factor: 49.962

3.  Human melatonin regulation is not mediated by the three cone photopic visual system.

Authors:  G C Brainard; J P Hanifin; M D Rollag; J Greeson; B Byrne; G Glickman; E Gerner; B Sanford
Journal:  J Clin Endocrinol Metab       Date:  2001-01       Impact factor: 5.958

4.  Amino acid, glucose, and lactic acid utilization in vivo by rat tumors.

Authors:  L A Sauer; J W Stayman; R T Dauchy
Journal:  Cancer Res       Date:  1982-10       Impact factor: 12.701

5.  13-Hydroxyoctadecadienoic acid is the mitogenic signal for linoleic acid-dependent growth in rat hepatoma 7288CTC in vivo.

Authors:  L A Sauer; R T Dauchy; D E Blask; B J Armstrong; S Scalici
Journal:  Cancer Res       Date:  1999-09-15       Impact factor: 12.701

6.  Dark-phase light contamination disrupts circadian rhythms in plasma measures of endocrine physiology and metabolism in rats.

Authors:  Robert T Dauchy; Erin M Dauchy; Robert P Tirrell; Cody R Hill; Leslie K Davidson; Michael W Greene; Paul C Tirrell; Jinghai Wu; Leonard A Sauer; David E Blask
Journal:  Comp Med       Date:  2010-10       Impact factor: 0.982

Review 7.  Changes in body composition in response to challenges during aging in rats.

Authors:  Tami Wolden-Hanson
Journal:  Interdiscip Top Gerontol       Date:  2010-08-10

8.  Rod photoreceptors drive circadian photoentrainment across a wide range of light intensities.

Authors:  Cara M Altimus; Ali D Güler; Nazia M Alam; A Cyrus Arman; Glen T Prusky; Alapakkam P Sampath; Samer Hattar
Journal:  Nat Neurosci       Date:  2010-08-15       Impact factor: 24.884

9.  Melanopsin and rod-cone photoreceptive systems account for all major accessory visual functions in mice.

Authors:  S Hattar; R J Lucas; N Mrosovsky; S Thompson; R H Douglas; M W Hankins; J Lem; M Biel; F Hofmann; R G Foster; K-W Yau
Journal:  Nature       Date:  2003-06-15       Impact factor: 49.962

Review 10.  Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.

Authors:  Russel J Reiter; Sergio A Rosales-Corral; Dun-Xian Tan; Dario Acuna-Castroviejo; Lilan Qin; Shun-Fa Yang; Kexin Xu
Journal:  Int J Mol Sci       Date:  2017-04-17       Impact factor: 5.923

View more
  8 in total

Review 1.  Cancer and the Circadian Clock.

Authors:  Ayesha A Shafi; Karen E Knudsen
Journal:  Cancer Res       Date:  2019-07-12       Impact factor: 12.701

Review 2.  Circadian Rhythms, Disease and Chronotherapy.

Authors:  Yool Lee; Jeffrey M Field; Amita Sehgal
Journal:  J Biol Rhythms       Date:  2021-09-22       Impact factor: 3.649

Review 3.  The Prospective Application of Melatonin in Treating Epigenetic Dysfunctional Diseases.

Authors:  Seth Mikaye Monayo; Xin Liu
Journal:  Front Pharmacol       Date:  2022-05-20       Impact factor: 5.988

4.  Effects of Daytime Blue-Enriched LED Light on Physiologic Parameters of Three Common Mouse Strains Maintained on an IVC System.

Authors:  George B Voros; Robert T Dauchy; Leann Myers; Steven M Hill; David E Blask; Georgina L Dobek
Journal:  J Am Assoc Lab Anim Sci       Date:  2021-03-05       Impact factor: 1.232

Review 5.  Melatonin as an Antitumor Agent against Liver Cancer: An Updated Systematic Review.

Authors:  Paula Fernández-Palanca; Carolina Méndez-Blanco; Flavia Fondevila; María J Tuñón; Russel J Reiter; José L Mauriz; Javier González-Gallego
Journal:  Antioxidants (Basel)       Date:  2021-01-12

Review 6.  Melatonin and Pathological Cell Interactions: Mitochondrial Glucose Processing in Cancer Cells.

Authors:  Russel J Reiter; Ramaswamy Sharma; Sergio Rosales-Corral; Walter Manucha; Luiz Gustavo de Almeida Chuffa; Debora Aparecida Pires de Campos Zuccari
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

Review 7.  Roles of circadian clocks in cancer pathogenesis and treatment.

Authors:  Yool Lee
Journal:  Exp Mol Med       Date:  2021-10-07       Impact factor: 8.718

Review 8.  Melatonin and circadian rhythms in liver diseases: Functional roles and potential therapies.

Authors:  Keisaku Sato; Fanyin Meng; Heather Francis; Nan Wu; Lixian Chen; Lindsey Kennedy; Tianhao Zhou; Antonio Franchitto; Paolo Onori; Eugenio Gaudio; Shannon Glaser; Gianfranco Alpini
Journal:  J Pineal Res       Date:  2020-03-04       Impact factor: 13.007

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.